443 related articles for article (PubMed ID: 18093762)
1. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
[TBL] [Abstract][Full Text] [Related]
2. Crystallization and polymorphic transitions of chlorpropamide in aqueous 2-hydroxybutyl-beta-cyclodextrin solution.
Ishiguro T; Hirayama F; Iohara D; Arima H; Uekama K
Eur J Pharm Sci; 2010 Feb; 39(4):248-55. PubMed ID: 20036739
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-based isolation of Ostwald's metastable polymorphs occurring during crystallization.
Sonoda Y; Hirayama F; Arima H; Yamaguchi Y; Saenger W; Uekama K
Chem Commun (Camb); 2006 Feb; (5):517-9. PubMed ID: 16432568
[TBL] [Abstract][Full Text] [Related]
4. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
5. Stability of natamycin and its cyclodextrin inclusion complexes in aqueous solution.
Koontz JL; Marcy JE; Barbeau WE; Duncan SE
J Agric Food Chem; 2003 Nov; 51(24):7111-4. PubMed ID: 14611180
[TBL] [Abstract][Full Text] [Related]
6. Solubilization and quantification of lycopene in aqueous media in the form of cyclodextrin binary systems.
Vertzoni M; Kartezini T; Reppas C; Archontaki H; Valsami G
Int J Pharm; 2006 Feb; 309(1-2):115-22. PubMed ID: 16376501
[TBL] [Abstract][Full Text] [Related]
7. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
8. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
[TBL] [Abstract][Full Text] [Related]
9. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
10. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
11. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
[TBL] [Abstract][Full Text] [Related]
12. Formulation of indomethacin eye drops via complexation with cyclodextrins.
Halim Mohamed MA; Mahmoud AA
Curr Eye Res; 2011 Mar; 36(3):208-16. PubMed ID: 21275515
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in beta-cyclodextrin-benzoic acid inclusion complex: a kinetically controlled crystal growth according to the Ostwald's rule.
Aree T; Chaichit N; Engkakul C
Carbohydr Res; 2008 Sep; 343(14):2451-8. PubMed ID: 18653173
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of gastric toxicity of indomethacin acid, salt form and complexed forms with hydroxypropyl-beta-cyclodextrin on Wistar rats: histopathologic analysis.
Ribeiro-Rama AC; Figueiredo IV; Veiga F; Castel-Branco MM; Cabrita AM; Caramona MM
Fundam Clin Pharmacol; 2009 Dec; 23(6):747-55. PubMed ID: 19656206
[TBL] [Abstract][Full Text] [Related]
15. Effect of dimethyl-beta-cyclodextrin on nitrazepam stability.
Saleh SI; Rahman AA; Aboutaleb AE; Nakai Y; Ahmed MO
J Pharm Belg; 1993; 48(5):383-8. PubMed ID: 8120792
[TBL] [Abstract][Full Text] [Related]
16. Enhanced stability of sulfamethoxazole and trimethoprim against oxidation using hydroxypropyl-beta-cyclodextrin.
Pourmokhtar M; Jacobson GA
Pharmazie; 2005 Nov; 60(11):837-9. PubMed ID: 16320945
[TBL] [Abstract][Full Text] [Related]
17. Comparative enantioseparations with native beta-cyclodextrin and heptakis-(2-O-methyl- 3,6-di-O-sulfo)-beta-cyclodextrin in capillary electrophoresis.
Chankvetadze B; Burjanadze N; Maynard DM; Bergander K; Bergenthal D; Blaschke G
Electrophoresis; 2002 Sep; 23(17):3027-34. PubMed ID: 12207312
[TBL] [Abstract][Full Text] [Related]
18. Study of branched cationic beta-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel.
Xin J; Guo Z; Chen X; Jiang W; Li J; Li M
Int J Pharm; 2010 Feb; 386(1-2):221-8. PubMed ID: 19945520
[TBL] [Abstract][Full Text] [Related]
19. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
20. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
